Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (51-60 of 365) with videos related to

Pageof 37
Sort By:
Breast Cancer Research and Treatment|January 1, 1982
Metabolites of tamoxifen in animals and man: identification, pharmacology, and significanceV C Jordan
Pharmacological Reviews|December 1, 1984
Biochemical pharmacology of antiestrogen actionV C Jordan
Journal of Women'S Health|June 1, 1997
After the menopause: tamoxifen and other new prevention maintenance therapiesV C Jordan
Journal of the National Cancer Institute|June 4, 1997
Tamoxifen: the herald of a new era of preventive therapeuticsV C Jordan
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Tumoristatic action of tamoxifen: experimental evidence for clinical application in stage I and II breast cancerV C Jordan
British Journal of Pharmacology|November 23, 2006
Beyond raloxifene for the prevention of osteoporosis and breast cancerV C Jordan
Journal of the National Cancer Institute|June 20, 1990
Node-negative breast cancer: tamoxifen and chemosuppressionV C Jordan
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Chemotherapy is antihormonal therapy--how much proof do oncologists need?V C Jordan
Journal of Reproduction and Fertility|February 1, 1975
Prolonged antioestrogenic activity of ICI 46, 474 in the ovariectomized mouseV C Jordan
The Lancet. Oncology|March 22, 2002
Tamoxifen: a personal retrospectiveV C Jordan
Pageof 37

Showing results (51-60 of 365) with videos related to

Sort By:
Pageof 37
Breast Cancer Research and Treatment|January 1, 1982
Metabolites of tamoxifen in animals and man: identification, pharmacology, and significanceV C Jordan
Pharmacological Reviews|December 1, 1984
Biochemical pharmacology of antiestrogen actionV C Jordan
Journal of Women'S Health|June 1, 1997
After the menopause: tamoxifen and other new prevention maintenance therapiesV C Jordan
Journal of the National Cancer Institute|June 4, 1997
Tamoxifen: the herald of a new era of preventive therapeuticsV C Jordan
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Tumoristatic action of tamoxifen: experimental evidence for clinical application in stage I and II breast cancerV C Jordan
British Journal of Pharmacology|November 23, 2006
Beyond raloxifene for the prevention of osteoporosis and breast cancerV C Jordan
Journal of the National Cancer Institute|June 20, 1990
Node-negative breast cancer: tamoxifen and chemosuppressionV C Jordan
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Chemotherapy is antihormonal therapy--how much proof do oncologists need?V C Jordan
Journal of Reproduction and Fertility|February 1, 1975
Prolonged antioestrogenic activity of ICI 46, 474 in the ovariectomized mouseV C Jordan
The Lancet. Oncology|March 22, 2002
Tamoxifen: a personal retrospectiveV C Jordan
Pageof 37